Cinacalcet Tablet, Film Coated
Product Images NDC 63629-9606

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 63629-9606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cinacalcet-fig3 (Cinacalcet Fig3)

A line graph depicting serum calcium levels (mg/dL) over an 80-week period in patients with parathyroid carcinoma. The x-axis represents weeks, subdivided into titration and maintenance phases, while the y-axis shows calcium levels. Data points include error bars indicating variability, with decreasing calcium levels during titration and stabilization during maintenance.*

FDA Label Image

Cinacalcet-fig4.jpg (Cinacalcet Fig4)

This is a line graph depicting calcium levels (mg/dL) over a span of 80 weeks. The x-axis represents weeks, divided into titration and maintenance phases, while the y-axis shows calcium levels ranging from 8 to 15 mg/dL. Data points include error bars and sample size noted below the x-axis. The graph monitors calcium level changes over the treatment duration.*

FDA Label Image

Cinacalcet-figure-1.jpg (Cinacalcet Figure 1)

A line graph titled 'Mean (SE) iPTH Values (Pooled Phase 3 Studies)' comparing placebo and Cinacalcet over 26 weeks. The y-axis shows iPTH levels in pg/mL from 0 to 1000, and the x-axis shows weeks from 0 to 26. The graph illustrates iPTH values decreasing over time for Cinacalcet and remaining relatively stable for placebo.*

FDA Label Image

Cinacalcet-figure-2 (Cinacalcet Figure 2)

Line graph titled 'Mean (SE) Ca x P Values (Pooled Phase 3 Studies)' comparing calcium-phosphorus product levels (mg/dL) over 26 weeks between placebo and Cinacalcet groups. The Ciancalcet group shows a decreasing trend and lower values compared to placebo throughout the study period.*

FDA Label Image

Cinacalcet-str (Cinacalcet Str)

Chemical structure diagram of cinacalcet hydrochloride, showing the molecular arrangement with a trifluoromethyl-substituted phenyl ring and a naphthylmethyl group linked by an amine and a methyl substituent.*

FDA Label Image

Label (Lbl636299606)

Cinacalcet Tablets 90 mg film-coated oral tablets label showing the product name and strength prominently. The label includes the NDC 63629-9606-1, manufacturer Bryant Ranch Prepack, and a quantity of 30 tablets. Storage and handling instructions are listed on the left side with barcodes also present. The label states Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.